295 related articles for article (PubMed ID: 10676597)
1. Amiodarone: what have we learned from clinical trials?
Naccarelli GV; Wolbrette DL; Dell'Orfano JT; Patel HM; Luck JC
Clin Cardiol; 2000 Feb; 23(2):73-82. PubMed ID: 10676597
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone: clinical trials.
Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
[TBL] [Abstract][Full Text] [Related]
3. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Klein H; Auricchio A; Reek S; Geller C
Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
[TBL] [Abstract][Full Text] [Related]
4. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
Cappato R
Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
[TBL] [Abstract][Full Text] [Related]
5. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
Farré J; Cabrera JA; Romero J; Rubio JM
Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
9. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
Farré J; Romero J; Rubio JM; Ayala R; Castro-Dorticós J
Am J Cardiol; 1999 Mar; 83(5B):55D-63D. PubMed ID: 10089841
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.
Schläpfer J; Rapp F; Kappenberger L; Fromer M
J Am Coll Cardiol; 2002 Jun; 39(11):1813-9. PubMed ID: 12039497
[TBL] [Abstract][Full Text] [Related]
12. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
13. Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
Cooley R; Akhtar M; Sra J
Curr Cardiol Rep; 1999 Nov; 1(4):268-73. PubMed ID: 10980853
[TBL] [Abstract][Full Text] [Related]
14. Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH).
Oseroff O; Retyk E; Bochoeyer A
Curr Opin Cardiol; 2004 Jan; 19(1):26-30. PubMed ID: 14688631
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
Böcker D; Breithardt G
Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
Steinbeck G; Greene HL
Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
[TBL] [Abstract][Full Text] [Related]
17. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
Singh BN
Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733
[TBL] [Abstract][Full Text] [Related]
18. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function?
Block M; Hammel D; Böcker D; Borggrefe M; Breithardt G
Am J Cardiol; 1996 Sep; 78(5A):62-8. PubMed ID: 8820838
[TBL] [Abstract][Full Text] [Related]
19. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
Block M; Breithardt G
Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
[TBL] [Abstract][Full Text] [Related]
20. Ventricular arrhythmias and sudden cardiac death: an insight from recent multicenter randomized clinical trials.
Akiyama T
Keio J Med; 1996 Dec; 45(4):313-7. PubMed ID: 9023449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]